Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    The U.S. Oil Export Ban Is a Windfall for These Companies

    After more than four decades, it looks like America is getting back into the oil export business again.

    For the first time since the 1970s, Washington has opened the door to sending more U.S. crude abroad.

    Of course, the United States has been exporting oil products for some time now.

    In fact, America is now the largest exporter of products like gasoline, low-sulfur heating oil, and diesel fuel in the world.

    But until now, companies were hamstrung when it came to the raw material itself.

    Of course, there have been a few exceptions. Very heavy California crude, which has to be sold at a deep discount and for which there is not a ready domestic market, has received some permissions to export. In addition, a few tolling programs - where the raw material is exported out and finished products are imported back in - have been allowed.

    But for the lion's share of what is pumped out of the ground at American fields, the domestic market has long been the only option.

    This change in policy promises to open up new opportunities for investors... Full Story


    Read More...
  • U.S. Oil Exports